Leadership and History
About Us
Our work is shaped by experience, collaboration, and strong connections. Get to know our management team and the networks we’re part of.
Leadership Team
History
Memberships
Publications
Our Strength
At Staburo, our greatest asset is our people. With a team of over 100 professionals based in Munich and supporting clients across the globe, we bring together deep expertise in biostatistics, data science, bioinformatics, statistical programming, and beyond. Our team members hold advanced degrees across a wide range of disciplines, and many have years of hands-on experience in clinical research and the pharmaceutical industry.
Managing Directors
Dr. Hannes Buchner
Head of Biostatistics and Managing Director
Oncology and many other indications – Longitudinal biomarkers – Expert in crossover correction methods
Dr. Josef Höfler
Head of Biostatistics and Managing Director
Oncology and respiratory indications – Biomarkers – Translational data – Non-inferiority study designs – Strategic support for clinical development programs
Roland Stieger
Head of Commercial Operations and Managing Director
Business development and marketing – Proposal and contract management – Point of contact for clients
Management Team
Katrin Frank
Head of Corporate Functions
Dr. Luciana Husfeld
Head of Quality Assurance
Nataliya Shvaykovska
Head of IT
Dr. Stefan Bentink
Director Data Science & Diagnostics
Angelika Böhm
Director Programming & Visualisation
Habib Esmaeili, PhD
Director Data Transparency & Medical Writing
Dr. Lena Herich
Director Clinical Statistics
Lauri Õnnik
Director Data Management
Dr. Janine Roy
Director Bioinformatics & Data Analytics
Laura Schlieker
Director Biostatistics Focus Area Biomarker
Our History
Founded in Munich in 2010, we have grown steadily over the years, from a small idea at UnternehmerTUM to a team of 100 employees in 2025. Today, we continue building on this foundation, focusing on sustainable development and long-term partnerships.
Memberships
& Awards
BVMA
“Bundesverband Medizinischer Auftragsinstitute” / Federal Association of Contract Research Organisations was founded in 1991 in order to represent CROs (Contract Research Organisations) which are based in Germany or German speaking countries. The BVMA is based in Munich.
EFSPI
The European Federation of Statisticians in the Pharmaceutical Industry, is open to constituted groups of statisticians. They are engaged in statistical aspects of research, development, production, and surveillance of drugs and medical devices. Several of our employees are members of the ‘Reporting’ subteam of the Estimand Implementation Working Group (EIWG).
PSI
Statisticians in the Pharmaceutical Industry (PSI) is a community dedicated to leading and promoting the use of statistics within the healthcare industry for the benefit of patients. Several of our employees are members in special interest groups of PSI, like AIMS SIG, Biomarkers, CMC Statistical Network Europe, ctDNA, Vaccines.
APF
“Arbeitsgruppe Pharmazeutische Forschung” is a working group for pharmaceutical research and development under the umbrella of the German region of the international Biometric Society. APF aspires to connect data scientists working in the field of pharmaceutical research and development. Several of our employees are active members of APF.
EMWA
European Medical Writers Association is a network of professionals representing, supporting, and training medical communicators. It is a not-for-profit organisation run for its members by its members. Several of our employees are active members of EMWA.
Kununu Top Company Award
Kununu is Europe’s largest employer review platform, giving employees a space to share honest feedback about their workplace. Since 2024, we have received the Kununu Top Company Award every year.
Check Out Our Publications
New publication in BMC Bioinformatics: shadowVIMP: permutation-based multiple testing-controlled variable selection
We’re pleased to share that our methodological work on variable selection with random forests has now been published in BMC Bioinformatics. The paper introduces shadowVIMP, a novel variable selection method based on random forest importance measures and...
Staburo Contributes to Bioinformatic Analysis in a Phase 2 Chronic Kidney Disease (CKD) Study
We are pleased that part of our work got published as a scientific article in the International Journal of Molecular Sciences on November 7th, 2025. In this publication, we supported the bioinformatic analysis in a study investigating the effect of Vicadrostat...
Staburo Contributes to Bioinformatic Analysis in Psoriasis Phase 2 Study
We are pleased that part of our work has been published as a letter to the author in the Journal of investigative dermatology. In this publication we supported the bioinformatic analysis in a study investigating the effect of spesolimab on microRNA expression in...
Ready to Collaborate?
Whether you need senior biostatistics support, reliable data science expertise, or strategic guidance for your clinical development programs, our team is here to help.